Hims & Hers' CEO Just Disposed of 78,859 Shares. Here's What Long-Term Investors Should Know.
Stock-based compensation vesting triggered mandatory tax withholding, but Dudum retains about 9.7 million shares worth $272 million.
Hims & Hers Health CEO Andrew Dudum recently sold 78,859 shares of the company's Class A Common Stock on August 14, according to a recent SEC Form 4 filing. The transaction, valued at $2.34 million based on a weighted average sale price of $28.15 per share, followed closely with the market price at $28.15 on the day of the sale.
Hims & Hers Health, a prominent digital health platform, boasts a market capitalization of $6.4 billion and reported $2.6 billion in total revenue for the trailing twelve months (TTM), marking its position at the crossroads of telehealth and direct-to-consumer pharmaceutical distribution. The company's integrated platform design offers competitive edges through operational efficiency, enhanced customer convenience, and personalized data-driven services.
Despite currently operating at a net loss of $142.0 million TTM, Hims & Hers Health's robust revenue stream and substantial market presence underscore the company's success in popularizing its digital-first healthcare delivery model among consumers.
Written by urgent.news from Motley Fool's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
